INVO Fertility (IVF) Notes Payables (2010 - 2025)

INVO Fertility has disclosed Notes Payables across 16 years of filings, most recently posting $880000.0 for Q3 2025.

• Quarterly Notes Payables fell 88.21% year-over-year to $880000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $880000.0 (down 88.21% YoY) and the FY2024 annual result came in at $5.2 million, up 87.17% from the prior year.
• Notes Payables eased to $880000.0 in Q3 2025, from $2.9 million in the prior quarter.
• Across five years, Notes Payables topped out at $7.5 million in Q3 2024 and bottomed at $157620.0 in Q1 2021.
• The 5-year median for Notes Payables is $2.7 million (2023), against an average of $2.7 million.
• Year-over-year, Notes Payables surged 262.41% in 2023 and slumped 88.21% in 2025.
• INVO Fertility's Notes Payables stood at $453406.0 in 2021, then surged by 68.2% to $762644.0 in 2022, then surged by 262.41% to $2.8 million in 2023, then jumped by 87.17% to $5.2 million in 2024, then slumped by 82.99% to $880000.0 in 2025.
• According to Business Quant data, Notes Payables over the past three periods registered $880000.0, $2.9 million, and $6.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.